Overview

Riluzole in Fragile X Syndrome

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the effectiveness and tolerability of riluzole in adults with Fragile X Syndrome.
Phase:
Phase 4
Details
Lead Sponsor:
Indiana University
Collaborator:
Indiana Clinical and Translational Sciences Institute
Treatments:
Riluzole